Search Orphan Drug Designations and Approvals
-
Generic Name: | Benzyl ethyl aminoazobenzene quaternary ammonium |
---|---|
Date Designated: | 03/17/2022 |
Orphan Designation: | Treatment of Retinitis Pigmentosa (RP) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Kiora Pharmaceuticals, Inc. 1371 East 2100 South Suite 200 Salt Lake City, Utah 84105 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-